Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 31
Encontrada(s) 1 página(s)

DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

Designing Polyelectrolyte Microneedles Based on Borylated Poly(β-aminoester) Polymers To Enhance Transdermal pH-Controlled Delivery of Nucleic Acids

  • Gonzalez-Saenz, Patricia
  • Cosialls, Raúl
  • Texidó Bartes, Robert
  • Dols-Perez, Aurora
  • Cuenca, Ana Belen
  • Borrós, Salvador
  • Fornaguera, Cristina
The use of transdermal delivery for nucleic acidadministration is an interesting approach to overcoming limitations ofsystemic administration routes, such as first-pass effects, the painfulneedle injection, or their poor biodistribution. Thus, the use of amicroneedle-based patch could represent a turning point for nucleic aciddelivery, thanks to the possibility of self-administration of the actives in apainless and easy procedure. However, the design of transdermal systemswith a higher degree of precision release is a clear need that has not beenfully resolved. Committed to tackling this challenge, we present here amicroneedle patch that involves a smart delivery system supported by thewell-established ability of boronic acid to interact with carbohydrates in apH-dependent manner. This system builds up a multilayer structure overa solid microneedle platform whose surface has been modified toimmobilize glucosamine units that are able to interact with anoligopeptide-end terminated poly(β-aminoester) that presents a 4-carboxy-3-fluorophenylboronic acid (Bor-pBAE). Thus,sequential layers of the Bor-pBAE and plasmid DNA have been assembled, thanks to the ability of the polymer to interact withthe nucleic acid at a basic pH and then gradually release the plasmid under two different conditions of pH (the physiological pH =7.4 and the acidic pH = 5.1). We set up the design and implementation of this first proof of concept while demonstratingmicroneedles' safety and functionality. Additionally, we have shown the efficacy of the construct to express the encoded genes inmodel cell lines. In conclusion, we have established the basis to confirm that this generation of borylated poly(β-aminoesters) holdsgreat promise as a transdermal local nucleic acid delivery system., info:eu-repo/semantics/publishedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

Localized doxycycline delivery via polymeric nanoparticles anchored to electrospun PCL microfiber patch for MMP-2 inhibition in abdominal aortic aneurysm

  • Bofill Bonet, Carles
  • Febas, Germán
  • Artigues Cladera, Margalida
  • Moreno-Jimenez, Ines
  • Balà Palasí, Noemí
  • Martorell, Jordi
  • Borrós, Salvador
  • Fornaguera, Cristina
Doxycycline (DOXY) is a well-established antibiotic that has recently shown potential in inhibiting matrix metalloproteinase-2 (MMP-2), a key enzyme involved in the progression of abdominal aortic aneurysms (AAA). However, the controlled delivery of DOXY to the aneurysm site, with sustained release and minimal systemic exposure, remains a critical challenge in therapeutic development. To address this, we developed a targeted drug delivery platform based on polymeric nanoparticles (NPs), prepared from water-in-oil-in-water nano-emulsions, encapsulating DOXY and are covalently attached to electrospun ε-poly(caprolactone) (ε-PCL) microfibers. This system was designed to enable local, sustained drug release in the inner wall of aorta while preserving the mechanical properties of the aortic wall. The ε-PCL electrospun microfibers from the patch were first functionalized using oxygen cold plasma treatment, creating free radicals that enabled covalent bonding with chemical groups on the outer layer of DOXY-loaded poly(lactic-co-glycolic acid) (PLGA) NPs. This strategy allowed for robust immobilization of the NPs onto the microfibers surface, forming a composite system capable of localized and controlled drug release over time. Unlike traditional delivery approaches, this method ensures site-specific action of DOXY directly at the aneurysmal tissue, minimizing systemic circulation and reducing off-target toxicity. The platform not only provides a stable drug reservoir but also offers intrinsic biomechanical reinforcement, which is critical in AAA condition. This innovative delivery system represents a significant advance in the localized treatment of vascular disorders. It offers a biocompatible, biodegradable, and precisely targeted therapeutic approach, with potential to reduce the need for surgical intervention and limits the adverse effects associated with systemic drug administration., info:eu-repo/semantics/publishedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

CD47 peptide-albumin cloaked mesoporous silica nanoparticles for enhanced macrophage evasion and synergistic combination therapy

  • Pontón, Iris
  • Núñez Martínez-Quintanilla, Sandra
  • Díaz-Perlas, Cristina
  • Oller-Salvia, Benjamí
  • Semino, Carlos
  • Sánchez-García, David
Upon introduction into the bloodstream, nanoparticles are rapidly enveloped by plasma proteins, forming a protein corona (PC) that typically accelerates their clearance via opsonization and macrophage uptake. However, specific proteins, such as albumin, exhibit dysopsonin properties, reducing sequestration and prolonging systemic circulation. In this study, we have developed a nanocarrier (DOX/Ce6@MSN-EMal-BSA/SP1) based on mesoporous silica nanoparticles (MSNs) coated with a light-responsive PC that prevents macrophage recognition and enables the controlled release of doxorubicin (DOX). The PC comprises bovine serum albumin (BSA) anchored to the MSN surface through a novel singlet oxygen-sensitive linker, with further functionalization using a CD47-mimetic peptide (SP1) to enhance immune evasion. BSA coating resulted in a 1.9-fold reduction in uptake by macrophage cultures compared to uncoated MSNs. Incorporation of SP1 further diminished macrophage internalization by 3.5-fold, as quantified by in vitro assays. Red light irradiation (660 nm) triggers cleavage of the singlet oxygen-sensitive linker, leading to PC shedding and subsequent DOX release. In vitro cytotoxicity evaluations against pancreatic cancer cell lines demonstrated potent efficacy: the nanocarrier exhibited an IC50 of 0.99 μg mL−1 against MIA PaCa-2 cells and 1.74 μg mL−1 against PANC-1 cells. This high cytotoxicity is attributed to a synergistic effect (CI = 0.40 for MIA PaCa-2 and 0.17 for PANC-1) resulting from the photodynamic generation of singlet oxygen by chlorin e6 (Ce6) and the chemotherapeutic action of released DOX. These findings underscore the nanocarrier's potential for precision drug delivery in combination therapeutic modalities., info:eu-repo/semantics/acceptedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

Quantitative and qualitative comparison of mRNA loading techniques into extracellular vesicles

  • Guarro, Monica
  • van Veen, Stijn
  • Borrós, Salvador
  • Albertazzi, Lorenzo
  • Lecina, Martí
  • Fornaguera, Cristina
Extracellular vesicles (EVs) are increasingly recognized as natural therapeutic delivery systems (DDS). A critical challenge in realizing this potential is the loading of nucleic acids, particularly mRNA, a high molecular weight and very sensitive biomolecule, for which the loading efficiency into EVs is often low. Despite the growing interest in EV-based delivery platforms, relatively few studies have reported efficient loading techniques, and inconsistent or misleading information in the literature hinders progress towards the development of reliable loading of mRNA into EV-based systems. Addressing this gap systematically and quantitatively is crucial for the clinical translation of EVs as DDS. In this study, we compared five different exogenous mRNA loading methods (incubation, sonication, freeze-thaw, electroporation and extrusion) and evaluated their loading efficiencies, as well as their biophysical, biochemical, and functional properties. Here, using direct stochastic optical reconstruction microscopy (dSTORM), as an efficient and reliable characterization approach to assess mRNA loading efficiency into EVs we visualized single EVs and single mRNA molecules and to estimate the percentage of loaded EVs as well as the amount of mRNA molecules loaded per EV. Interestingly, all five strategies demonstrated a high yield of EVs associated with mRNA, with up to 70 % of EVs successfully containing or in contact with mRNA, with minimal disruption to the intrinsic properties of EVs. Although some discrepancies between loading efficiencies, functionality and amount of mRNA molecules per EV, freeze-thaw proved to be the most effective in terms of loading efficiency and amount of mRNA associated molecules per EV. Overall, mRNA incorporation using these exogenous methods remained inefficient and presented significant challenges for large-scale implementation due to substantial mRNA loss. Despite this limitation, the high proportion of successfully loaded or mRNA associated EVs, particularly with freeze-thaw and electroporation, provides, for the first time, a promising foundation for the advancing of mRNA loading on EV-based therapeutic applications., info:eu-repo/semantics/publishedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

Sustainable encapsulation of lipophilic fragrances using biodegradable sodium alginate for cosmetic applications

  • Tarrats i Duran, Anna
  • Borrós, Salvador
  • Rodrigo Magaña, José
  • Fornaguera, Cristina
The encapsulation of lipophilic compounds for use in the cosmetic, food, and detergency industries is an area of growing interest. However, most current strategies rely on non-biodegradable materials, often classified as microplastics, which pose significant environmental risks. To address these issues, alternative encapsulation methods using biodegradable materials are being developed. Despite their potential, these methods have yet to demonstrate efficacy or economic feasibility comparable to conventional encapsulation systems. To overcome these challenges, a novel strategy has been developed for the encapsulation of lipophilic compounds, such as fragrances, using sodium alginate (SA). This approach involves the formation of an oil-in-water nanoemulsion via the Phase Inversion Composition method, with polysorbate 80 serving as the surfactant. The process is followed by the internal gelation of SA and subsequent dispersion to generate the final microcapsules. The formulation was optimized by varying the ratios of surfactant, oil, and aqueous phases in the nanoemulsion. Characterization techniques, including Dynamic Light Scattering, Gas Chromatography–Mass Spectrometry, and Thermogravimetric Analysis, confirmed successful encapsulation (average of 81 %, up to 97 % for one fragrance). The formulations demonstrated prolonged release profiles, with the scent remaining detectable for up to 30 days. An organoleptic study further revealed that encapsulated fragrances retained higher perceived intensity over time compared to their non-encapsulated counterparts. Moreover, the microcapsules exhibited excellent long-term stability within a conditioner matrix, maintaining their fragrance load for four months. This work represents a significant advancement in the development of environmentally friendly encapsulation methods for lipophilic compounds, offering promising applications in the cosmetic industry., info:eu-repo/semantics/acceptedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

Safety of nanoparticle therapies during pregnancy: A systematic review and meta-analysis

  • Gil Vives, Maria
  • Hernández Hernández, Marta
  • Hernáez, Álvaro
  • Borrós, Salvador
  • Fornaguera Puigvert, Cristina
The exclusion of pregnant women from clinical trials has led to insufficient safety data for many treatments, making it necessary to evaluate their potential benefits and risks during preclinical stages. Nanomedicines show potential for reduced toxicity but there is limited evidence about their safety for pregnant women and their fetuses. We conducted the first systematic review and meta-analysis of the effect of nanoparticles (NPs) on a key outcome of fetal toxicity (low birth weight) in murine models. In the meta-analysis of mouse models, negatively charged NPs tended to decrease birth weight (−69.8 mg, 95 % CI: −196 to 56.5), as did small (−191 mg, 95 % CI: −369 to −13.3) and plain inorganic nanosystems (−249 mg, 95 % CI: −535 to 37.4). In contrast, positively charged NPs resulted in increased birth weight (+29.3 mg, 95 % CI: 23.4 to 35.2). All findings were validated in studies with low heterogeneity and low risk of publication bias. Neither large NPs (+4.37 mg; 95 % CI: −45.3 to 54.0) nor polymer-coated NPs (+16.5 mg; 95 % CI: −44.7 to 77.6) had any clear association with birth weight. Similar results were observed in other models and experimental designs from articles not included in the meta-analysis, although no conclusions were drawn for other parameters due to high variability. Our findings pave the way for future research and the rational development of safer nanomedicines for use during pregnancy., info:eu-repo/semantics/publishedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

Ammonium trifluoroborate-modified poly(β-aminoesters): A case study for PET-guided in vivo pharmacokinetic studies of a non-viral gene delivery system

  • Cosialls, Raúl
  • Fernández, Odile
  • Simó , Cristina
  • Krishna Reddy, Pulagam
  • Guerra-Rebollo, Marta
  • Llop, Jordi
  • Fornaguera, Cristina
  • Cuenca, Ana Belen
  • Borrós, Salvador
Nucleic acid-based therapies have become a game-changing player in our way of conceiving pharmacology. Nevertheless, the inherent lability of the phosphodiester bond of the genetic material with respect to the blood nucleases severely hampers its delivery in naked form, therefore making it necessary to use delivery vectors. Among the potential non-viral vectors, polymeric materials such as the poly(β-aminoesters) (PBAEs) stand out as promising gene carriers thanks to their ability to condense nucleic acids in the form of nanometric polyplexes. To keep advancing these systems into their translational preclinical phases, it would be highly valuable to gain accurate insights of their in vivo pharmacokinetic profile. We envisaged that positron emission tomography (PET)-guided imaging could provide us with both, an accurate assessment of the biodistribution of PBAE-derived polyplexes, as well shed light on their clearance process. In this sense, taking advantage of the efficient [19F]-to-[18F]‑fluorine isotopic exchange presented by the ammonium trifluoroborate (AMBF3) group, we have designed and synthesized a new 18F-PET radiotracer based on the chemical modification of a linear poly(β-aminoester). As proof of concept, the incorporation of the newly developed 18F-PBAE into a model nanoformulation was shown to be fully compatible with the formation of the polyplexes, their biophysical characterization, and all their in vitro and in vivo functional features. With this tool in hand, we were able to readily obtain key clues about the pharmacokinetic behavior of a series of oligopeptide-modified PBAEs (OM-PBAEs). The observations described in this study allow us to continue supporting these polymers as an outstanding non-viral gene delivery vector for future applications., info:eu-repo/semantics/acceptedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

Metabolic engineering of Saccharomyces cerevisiae sphingolipid pathways for enhanced phytoceramide production

  • Guixeras-Carreras, Jordi
  • Caballé, Marc
  • Leivar, Pablo
  • De Mey, Marjan
  • Planas, Antoni
  • Fornaguera, Cristina
  • Artigues Cladera, Margalida
  • Faijes, Magda
Phytoceramides are essential sphingolipids that support skin barrier integrity and hydration, making them valuable for cosmetic and pharmaceutical applications. However, their intricate structures and low natural abundance pose significant challenges for scalable production. Here, we present an integrated metabolic engineering and lipidomics study aimed at enhancing phytoceramide production in Saccharomyces cerevisiae. We implemented three strategies: (i) overexpression of SUR2 (sphinganine C4-hydroxylase) to boost phytosphingolipid formation; (ii) deletion of SCS7 (ceramide α-hydroxylase) to redirect flux toward non-hydroxylated phytoceramides; and (iii) overexpression of ISC1 (inositol phosphosphingolipid phospholipase) to recycle complex sphingolipids into ceramide pools. SUR2 overexpression showed the highest transcript levels, whereas lipidomics revealed that scs7Δ produced the highest phytoceramide enrichment with a 15-fold increase in phytoceramide abundance relative to the wild type. In terms of relative abundance within the quantified ceramide pool, phytoceramides increased from 5% in wild type to 46% in the SUR2-OE strain and 75% in the scs7Δ strain. The combined scs7Δ SUR2-OE strain did not exhibit additive metabolic effects on the lipid profile. The presence of residual hydroxylated ceramides indicated intrinsic regulatory constraints, aligning with the bypass mechanism proposed here whereby ceramide synthases can use pre-hydroxylated acyl-CoA. Importantly, this work contributes a comprehensive lipidomic profiling of S. cerevisiae, enabling clear discrimination between engineered and wild type strains and identification of genotypes exerting the greatest impact on phytoceramide accumulation. This approach advances sphingolipid pathway modulation and positions S. cerevisiae as a valuable model for studying phytoceramide-focused remodeling., info:eu-repo/semantics/publishedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

Stealth mRNA nanovaccines to control lymph node trafficking

  • García-Fernández, Coral
  • Virgilio, Tommaso
  • Latino, Irene
  • Guerra-Rebollo, Marta
  • F. Gonzalez, Santiago
  • Borrós, Salvador
  • Fornaguera, Cristina
mRNA-based vaccines symbolize a new paradigm shift in personalized medicine for the treatment of infectious and non-infectious diseases. However, the reactogenicity associated with the currently approved formulations limits their applicability in autoinflammatory disorders, such as tumour therapeutics. In this study, we present a delivery system showing controlled immunogenicity and minimal non-specific inflammation, allowing for selective delivery of mRNA to antigen presenting cells (APCs) within the medullary region of the lymph nodes. Our platform offers precise control over the trafficking of nanoparticles within the lymph nodes by optimizing stealth and targeting properties, as well as the subsequent opsonization process. By targeting specific cells, we observed a potent adaptive and humoral immune response, which holds promise for preventive and therapeutic anti-tumoral vaccines. Through spatial programming of nanoparticle distribution, we can promote robust immunization, thus improving and expanding the utilization of mRNA vaccines. This innovative approach signifies a remarkable step forward in the field of targeted nanomedicine., info:eu-repo/semantics/publishedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

Fine-tuning formulation and biological interaction of doxorubicin-loaded polymeric nanoparticles via electrolyte concentration modulation, Fine-tuning formulation and biological interaction of doxorubicin-loaded polymeric nanoparticles via electrolyte concentration modulation

  • Bofill Bonet, Carles
  • Gil Vives, Maria
  • Artigues Cladera, Margalida
  • Hernández Hernández, Marta
  • Borrós, Salvador
  • Fornaguera, Cristina
Doxorubicin (DOX) is amongst the most widely used chemotherapeutic drugs against various cancers. However, its controlled biodistribution to the tumor site at the required pharmacokinetics profile remains challenging. In this work, a vast study of formulation parameters has been performed to control doxorubicin loading into polymeric nanoparticles in physiological conditions. Water-in-oil-in-water (W1/O/W2) template emulsions have been formulated, including doxorubicin in the internal water phase. Specifically, the system [Doxorubicin in aqueous solution (W1) / Pluronic F-127 (S) and PLGA in ethyl acetate (O)], [Polysorbate 80 (S) in water solution], using phosphate buffer on both aqueous phases at different electrolyte concentrations has been established. The first W1/O nano-emulsion was formed by high-speed homogenization, and the second O/W2 nano-emulsion was formed by the phase inversion composition method, a low-energy emulsification appropriated for pharmaceutical compounds. Although many previous studies had already used double emulsions for DOX encapsulation in nanofluids, here, for the first time, the salt concentration of the water phases has been varied to control the resulting doxorubicin and nanoparticle properties. The addition of high concentrations of electrolytes in both aqueous phases decreases the solubility and dissolution rates of the drug, leading to a high degree of DOX dimerization. This phenomenon significantly impacts the internalization and subcellular localization. Facilitating drug nuclear accumulation is of vital interest, and this is primarily achieved when doxorubicin is incorporated into nanoparticles formulated with PBS at low electrolyte concentrations (2.5 mM), which exhibit exceptional internalization properties. Thus, it has been demonstrated that doxorubicin loading in polymeric nanoparticles can be tuned by only varying salt concentrations of template W1/O/W2 emulsions. Consequently, our results show the adequacy of the double nano-emulsion templating for the generation of non-toxic DOX-loaded polymeric nanoparticles with different physicochemical properties and interaction with the cell surface that would allow their use for various anticancer therapies., info:eu-repo/semantics/acceptedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

A dual QTOF–QTrap analytical platform for comprehensive tracking of doxycycline and its degradation byproducts in biological and nanoparticle-based delivery systems

  • Bofill Bonet, Carles
  • Artigues Cladera, Margalida
  • Moreno-Jimenez, Ines
  • Balà, Noemí
  • Martorell, Jordi
  • Fornaguera, Cristina
  • Borrós, Salvador
Doxycycline (DOX) is a second-generation tetracycline antibiotic extensively used in clinical practice, not only for its antimicrobial activity but also for its emerging therapeutic potential in modulating extracellular matrix (ECM) in remodeling processes. Increasing evidence supports its role in attenuating pathological conditions associated with ECM degradation by targeting matrix metalloproteinases type 2 (MMP-2), including cancer progression and abdominal aortic aneurysm (AAA). However, DOX exhibits limited stability in aqueous and semi-physiological environments, undergoing hydrolysis and oxidative reactions that lead to the generation of multiple degradation byproducts, thereby compromising its efficacy and safety profile. In this study, we systematically mapped the degradation pathways of DOX under rigorously controlled physicochemical and biological conditions. High-resolution QTOF mass spectrometry operating in SWATH data-independent acquisition mode enabled unbiased identification of multiple, structurally distinct degradation byproducts, as well as the DOX parent compound, using curated metabolite libraries from SCIEX platform. Building on this annotation step, we established a complementary QTrap-based targeted workflow to quantify low-abundance metabolites intra- and extracellular through isotope-specific transitions derived from the QTOF analysis and to monitor their temporal kinetics with high sensitivity. Together, this integrated analytical strategy provides refined insight into the intrinsic instability of DOX and its potential biological consequences. To translate degradation mapping into a biologically relevant context, OM-PLGA NPs were incorporated as a controlled delivery platform that modulates DOX exposure, slows spontaneous degradation, and creates the matrix conditions required to validate the sensitivity of the QTRAP workflow in complex cellular environments. This validation demonstrated that OM-PLGA nanoparticles not only preserve DOX in its bioactive form through microenvironmental shielding, but also results in enhanced pharmacological activity, particularly sustained inhibition of MMP-2, a central enzyme in AAA-associated ECM remodeling. Together, these results highlight the dual value of the advanced analytical workflow and the nanocarrier strategy, demonstrating how integrating high-resolution mass spectrometry with nanoparticle engineering overcomes the intrinsic instability of DOX and provides deeper mechanistic insight across both analytical and biological dimensions., info:eu-repo/semantics/publishedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

Functionalised gold nanoparticles using abietane diterpenoids from Plectranthus grandidentatus Gürke for cancer therapy

  • Bangay, Gabrielle
  • Isca, Vera
  • Morais, João
  • Fernandez Alarcon, Jennifer
  • S. Viana, Ana
  • Reis, Catarina
  • Pereira Leite, Catarina
  • Ana M., Díaz Lanza
  • Saraiva, Lucília
  • Fornaguera, Cristina
  • Rijo, Patrícia Dias de Mendonça
Nanoparticles (NPs) are very small particles with distinct properties stemming from their nanometric size and large surface area, setting them apart from bulk materials. NPs provide many benefits, such as high drug loading capacity, specific targeting, prolonged circulation, and minimized side effects. Over the past few years, metal-based NPs, such as gold NPs (AuNPs), have gained special attention due their surface plasmon resonance properties and use in drug and gene delivery, particularly in cancer treatment and theragnostics. Abietane diterpenoids, such as 7α-acetoxy-6β-hydroxyroyleanone (Roy) isolated from Plectranthus spp., are known to be cytotoxic agents, ideal for chemotherapeutic applications. Yet, their poor water solubility and low bioavailability limit their therapeutic efficacy. Harnessing the effectiveness of AuNPs, several nanosystems were made using Roy, the natural diterpene, and an ester derivative. After characterization of size, PDI, zeta potential and encapsulation efficiency, antitumour analysis using in vitro cancer cell models of breast cancer (MDA-MB-231, 4T1 and MCF7) were used to probe cytotoxic effect. Roy-functionalised AuNPs showed increased antitumour activity when compared with Roy alone, showcasing the improved antitumoral effect of the nanoformulation. In addition, the Roy-functionalised AuNPs showed selectivity for cancer cells over healthy human fibroblast (HDF) cells, a promising incentive for further development of natural diterpenoid nanosystems in cancer therapy., info:eu-repo/semantics/publishedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

From nucleotides to intact transcripts through oligonucleotides: Integrated chromatographic strategies for therapeutic mRNA characterization

  • Losada Baranera, Mar
  • GOTOR, GEMMA
  • Borrós, Salvador
  • Fornaguera, Cristina
Messenger RNA (mRNA) has emerged as a transformative modality for modern therapeutics, including vaccines and gene therapies. Ensuring the quality, safety, and efficacy of mRNA products requires the evaluation of critical quality attributes (CQAs) such as sequence integrity, nucleotide modifications, purity, and structural stability. The growing complexity of modified mRNA therapeutics highlights the need for robust and orthogonal analytical strategies. This review summarizes liquid chromatography (LC)-based workflows tailored for mRNA characterization including UV detection and mass spectrometry (MS) strategies. These include nucleoside-level analysis to identify chemical modifications and impurities, partial digestion with oligonucleotide mapping to assess sequence coverage and localization of modifications, and intact mRNA analysis to evaluate global structural integrity and encapsulation efficiency. Case studies illustrate practical applications by directly linking analytical workflows to specific CQAs and regulatory-relevant attributes. By leveraging advances in chromatography and mass spectrometry—including bioinert stationary phases, high-resolution detection, and ion-pairing strategies—these studies enable robust analysis of highly polar, charged, and high-molecular-weight mRNA species. The integration of complementary chromatographic and MS-based workflows supports comprehensive characterization, facilitates regulatory compliance, and informs process and formulation development, ultimately providing a coherent framework for quality control in emerging mRNA therapeutics., info:eu-repo/semantics/publishedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

Regulation of mitochondrial apoptosis via siRNA-loaded metallo-alginate hydrogels: A localized and synergistic antitumor therapy

  • Fernandez Alarcon, Jennifer
  • Artigues Cladera, Margalida
  • Rodriguez Camenforte, Natalia
  • Sitia, Giovanni
  • Guerra-Rebollo, Marta
  • Borrós, Salvador
  • Fornaguera, Cristina
Preventing relapse after resection of a primary tumor continues to be an unmet clinical need. Development of adjuvant biomaterials with the capacity to kill residual cancer cells after tumor resection is of clinical importance. Here we developed a library of metallo-alginate hydrogels containing high concentrations of metallic ions such as Ca2+ in combination with Zn2+, Li+, or Mg2+ to disrupt Ca2+ homeostasis in the mitochondria of cancer cells by local hyperthermia. To synergistically kill tumor cells and suppress the growth of rechallenged tumors, we embedded oncogene-silencing nucleic acids (mTOR siRNA) loaded into polymerc nanoparticles (NPs) composed of poly (β-amino esters) in the metallo-alginate hydrogels, targeting cancer cells that activate multi-drug resistance pathways such PI3K/AKT/mTOR. Metabolomic studies showed alterations in the Warburg effect, mitochondrial transport, and the TCA cycle, confirming cancer cell damage. In vivo studies of this targeted therapy in mice demonstrated a sex-dependent effect. Male B16F10-tumor-bearing mice treated with the synergistic therapy showed restrained tumor growth. In contrast, no therapeutic effect was observed in female counterparts. Our results demonstrate that in situ-formed NP-loaded metallo-alginate hydrogels can modulate two distinct immune signaling networks that are relevant for enhancing cancer cell death. On the basis of our findings, this combination therapy emerges as a promising sex-dependent strategy for clinical translation., info:eu-repo/semantics/publishedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

Bovine serum albumin nanoparticles as a long-acting antiviral delivery platform for mycophenolic acid and ribavirin against emerging RNA viruses

  • Castañeda Cataña, Mayra Alejandra
  • Morrone, Josefina
  • Carlucci, Maria Josefina
  • Vásquez, Cecilia A.
  • Damonte, Elsa
  • Borrós, Salvador
  • Fornaguera, Cristina
  • Sepúlveda, Claudia
Bovine serum albumin nanoparticles (BSA NP) encapsulating mycophenolic acid (MPA) and ribavirin (RBV) were developed as a sustained-release antiviral platform to address the limitations of conventional therapies against Zika (ZIKV) and Junín (JUNV) viruses. The BSA NP exhibited reproducible physicochemical properties, high drug loading efficiency, and excellent hemocompatibility (< 2% hemolysis). Cellular uptake studies revealed progressive internalization and prolonged intracellular retention, while antiviral assays demonstrated that encapsulated MPA and RBV maintained efficacy at 100- and 200-fold lower concentrations than their free forms, with activity lasting up to 96 h after a single dose. Furthermore, protein corona analysis with fibrinogen, albumin, and isoenzyme II showed how surface interactions influence NP stability and potential biodistribution. These findings are significant as they demonstrate that BSA represent a solid alternative to conventional treatments by sustaining intracellular levels and reducing systemic toxicity, offering a safe, biocompatible, and long-acting macromolecular platform for clinical antiviral applications. Overall, this study demonstrates that BSA-based NP constitute a non-immunogenic and effective long-acting delivery strategy that markedly enhances the intracellular exposure and antiviral performance of clinically validated broad-spectrum antivirals, supporting their potential as a solid alternative to conventional dosing regimens limited by toxicity and rapid clearance. In conclusion, BSA NPs represent a solid alternative to existing therapeutics by enhancing the therapeutic index of MPA and RBV, reducing systemic toxicity through controlled release, and providing a biocompatible platform for clinical antiviral applications., info:eu-repo/semantics/acceptedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

From nucleotides to intact transcripts through oligonucleotides: Integrated chromatographic strategies for therapeutic mRNA characterization

  • Losada Baranera, Mar
  • GOTOR, GEMMA
  • Borrós, Salvador
  • Fornaguera, Cristina
Messenger RNA (mRNA) has emerged as a transformative modality for modern therapeutics, including vaccines and gene therapies. Ensuring the quality, safety, and efficacy of mRNA products requires the evaluation of critical quality attributes (CQAs) such as sequence integrity, nucleotide modifications, purity, and structural stability. The growing complexity of modified mRNA therapeutics highlights the need for robust and orthogonal analytical strategies. This review summarizes liquid chromatography (LC)-based workflows tailored for mRNA characterization including UV detection and mass spectrometry (MS) strategies. These include nucleoside-level analysis to identify chemical modifications and impurities, partial digestion with oligonucleotide mapping to assess sequence coverage and localization of modifications, and intact mRNA analysis to evaluate global structural integrity and encapsulation efficiency. Case studies illustrate practical applications by directly linking analytical workflows to specific CQAs and regulatory-relevant attributes. By leveraging advances in chromatography and mass spectrometry—including bioinert stationary phases, high-resolution detection, and ion-pairing strategies—these studies enable robust analysis of highly polar, charged, and high-molecular-weight mRNA species. The integration of complementary chromatographic and MS-based workflows supports comprehensive characterization, facilitates regulatory compliance, and informs process and formulation development, ultimately providing a coherent framework for quality control in emerging mRNA therapeutics., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Designing Polyelectrolyte Microneedles Based on Borylated Poly(β-aminoester) Polymers To Enhance Transdermal pH-Controlled Delivery of Nucleic Acids

  • Gonzalez-Saenz, Patricia
  • Cosialls, Raúl
  • Texidó Bartes, Robert
  • Dols-Perez, Aurora
  • Cuenca, Ana Belen
  • Borrós, Salvador
  • Fornaguera, Cristina
The use of transdermal delivery for nucleic acidadministration is an interesting approach to overcoming limitations ofsystemic administration routes, such as first-pass effects, the painfulneedle injection, or their poor biodistribution. Thus, the use of amicroneedle-based patch could represent a turning point for nucleic aciddelivery, thanks to the possibility of self-administration of the actives in apainless and easy procedure. However, the design of transdermal systemswith a higher degree of precision release is a clear need that has not beenfully resolved. Committed to tackling this challenge, we present here amicroneedle patch that involves a smart delivery system supported by thewell-established ability of boronic acid to interact with carbohydrates in apH-dependent manner. This system builds up a multilayer structure overa solid microneedle platform whose surface has been modified toimmobilize glucosamine units that are able to interact with anoligopeptide-end terminated poly(β-aminoester) that presents a 4-carboxy-3-fluorophenylboronic acid (Bor-pBAE). Thus,sequential layers of the Bor-pBAE and plasmid DNA have been assembled, thanks to the ability of the polymer to interact withthe nucleic acid at a basic pH and then gradually release the plasmid under two different conditions of pH (the physiological pH =7.4 and the acidic pH = 5.1). We set up the design and implementation of this first proof of concept while demonstratingmicroneedles' safety and functionality. Additionally, we have shown the efficacy of the construct to express the encoded genes inmodel cell lines. In conclusion, we have established the basis to confirm that this generation of borylated poly(β-aminoesters) holdsgreat promise as a transdermal local nucleic acid delivery system., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Bovine serum albumin nanoparticles as a long-acting antiviral delivery platform for mycophenolic acid and ribavirin against emerging RNA viruses

  • Castañeda Cataña, Mayra Alejandra
  • Morrone, Josefina
  • Carlucci, Maria Josefina
  • Vásquez, Cecilia A.
  • Damonte, Elsa
  • Borrós, Salvador
  • Fornaguera, Cristina
  • Sepúlveda, Claudia
Bovine serum albumin nanoparticles (BSA NP) encapsulating mycophenolic acid (MPA) and ribavirin (RBV) were developed as a sustained-release antiviral platform to address the limitations of conventional therapies against Zika (ZIKV) and Junín (JUNV) viruses. The BSA NP exhibited reproducible physicochemical properties, high drug loading efficiency, and excellent hemocompatibility (< 2% hemolysis). Cellular uptake studies revealed progressive internalization and prolonged intracellular retention, while antiviral assays demonstrated that encapsulated MPA and RBV maintained efficacy at 100- and 200-fold lower concentrations than their free forms, with activity lasting up to 96 h after a single dose. Furthermore, protein corona analysis with fibrinogen, albumin, and isoenzyme II showed how surface interactions influence NP stability and potential biodistribution. These findings are significant as they demonstrate that BSA represent a solid alternative to conventional treatments by sustaining intracellular levels and reducing systemic toxicity, offering a safe, biocompatible, and long-acting macromolecular platform for clinical antiviral applications. Overall, this study demonstrates that BSA-based NP constitute a non-immunogenic and effective long-acting delivery strategy that markedly enhances the intracellular exposure and antiviral performance of clinically validated broad-spectrum antivirals, supporting their potential as a solid alternative to conventional dosing regimens limited by toxicity and rapid clearance. In conclusion, BSA NPs represent a solid alternative to existing therapeutics by enhancing the therapeutic index of MPA and RBV, reducing systemic toxicity through controlled release, and providing a biocompatible platform for clinical antiviral applications., info:eu-repo/semantics/acceptedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Fine-tuning formulation and biological interaction of doxorubicin-loaded polymeric nanoparticles via electrolyte concentration modulation, Fine-tuning formulation and biological interaction of doxorubicin-loaded polymeric nanoparticles via electrolyte concentration modulation

  • Bofill Bonet, Carles
  • Gil Vives, Maria
  • Artigues Cladera, Margalida
  • Hernández Hernández, Marta
  • Borrós, Salvador
  • Fornaguera, Cristina
Doxorubicin (DOX) is amongst the most widely used chemotherapeutic drugs against various cancers. However, its controlled biodistribution to the tumor site at the required pharmacokinetics profile remains challenging. In this work, a vast study of formulation parameters has been performed to control doxorubicin loading into polymeric nanoparticles in physiological conditions. Water-in-oil-in-water (W1/O/W2) template emulsions have been formulated, including doxorubicin in the internal water phase. Specifically, the system [Doxorubicin in aqueous solution (W1) / Pluronic F-127 (S) and PLGA in ethyl acetate (O)], [Polysorbate 80 (S) in water solution], using phosphate buffer on both aqueous phases at different electrolyte concentrations has been established. The first W1/O nano-emulsion was formed by high-speed homogenization, and the second O/W2 nano-emulsion was formed by the phase inversion composition method, a low-energy emulsification appropriated for pharmaceutical compounds. Although many previous studies had already used double emulsions for DOX encapsulation in nanofluids, here, for the first time, the salt concentration of the water phases has been varied to control the resulting doxorubicin and nanoparticle properties. The addition of high concentrations of electrolytes in both aqueous phases decreases the solubility and dissolution rates of the drug, leading to a high degree of DOX dimerization. This phenomenon significantly impacts the internalization and subcellular localization. Facilitating drug nuclear accumulation is of vital interest, and this is primarily achieved when doxorubicin is incorporated into nanoparticles formulated with PBS at low electrolyte concentrations (2.5 mM), which exhibit exceptional internalization properties. Thus, it has been demonstrated that doxorubicin loading in polymeric nanoparticles can be tuned by only varying salt concentrations of template W1/O/W2 emulsions. Consequently, our results show the adequacy of the double nano-emulsion templating for the generation of non-toxic DOX-loaded polymeric nanoparticles with different physicochemical properties and interaction with the cell surface that would allow their use for various anticancer therapies., info:eu-repo/semantics/acceptedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Regulation of mitochondrial apoptosis via siRNA-loaded metallo-alginate hydrogels: A localized and synergistic antitumor therapy

  • Fernandez Alarcon, Jennifer
  • Artigues Cladera, Margalida
  • Rodriguez Camenforte, Natalia
  • Sitia, Giovanni
  • Guerra-Rebollo, Marta
  • Borrós, Salvador
  • Fornaguera, Cristina
Preventing relapse after resection of a primary tumor continues to be an unmet clinical need. Development of adjuvant biomaterials with the capacity to kill residual cancer cells after tumor resection is of clinical importance. Here we developed a library of metallo-alginate hydrogels containing high concentrations of metallic ions such as Ca2+ in combination with Zn2+, Li+, or Mg2+ to disrupt Ca2+ homeostasis in the mitochondria of cancer cells by local hyperthermia. To synergistically kill tumor cells and suppress the growth of rechallenged tumors, we embedded oncogene-silencing nucleic acids (mTOR siRNA) loaded into polymerc nanoparticles (NPs) composed of poly (β-amino esters) in the metallo-alginate hydrogels, targeting cancer cells that activate multi-drug resistance pathways such PI3K/AKT/mTOR. Metabolomic studies showed alterations in the Warburg effect, mitochondrial transport, and the TCA cycle, confirming cancer cell damage. In vivo studies of this targeted therapy in mice demonstrated a sex-dependent effect. Male B16F10-tumor-bearing mice treated with the synergistic therapy showed restrained tumor growth. In contrast, no therapeutic effect was observed in female counterparts. Our results demonstrate that in situ-formed NP-loaded metallo-alginate hydrogels can modulate two distinct immune signaling networks that are relevant for enhancing cancer cell death. On the basis of our findings, this combination therapy emerges as a promising sex-dependent strategy for clinical translation., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Functionalised gold nanoparticles using abietane diterpenoids from Plectranthus grandidentatus Gürke for cancer therapy

  • Bangay, Gabrielle
  • Isca, Vera
  • Morais, João
  • Fernandez Alarcon, Jennifer
  • S. Viana, Ana
  • Reis, Catarina
  • Pereira Leite, Catarina
  • Ana M., Díaz Lanza
  • Saraiva, Lucília
  • Fornaguera, Cristina
  • Rijo, Patrícia Dias de Mendonça
Nanoparticles (NPs) are very small particles with distinct properties stemming from their nanometric size and large surface area, setting them apart from bulk materials. NPs provide many benefits, such as high drug loading capacity, specific targeting, prolonged circulation, and minimized side effects. Over the past few years, metal-based NPs, such as gold NPs (AuNPs), have gained special attention due their surface plasmon resonance properties and use in drug and gene delivery, particularly in cancer treatment and theragnostics. Abietane diterpenoids, such as 7α-acetoxy-6β-hydroxyroyleanone (Roy) isolated from Plectranthus spp., are known to be cytotoxic agents, ideal for chemotherapeutic applications. Yet, their poor water solubility and low bioavailability limit their therapeutic efficacy. Harnessing the effectiveness of AuNPs, several nanosystems were made using Roy, the natural diterpene, and an ester derivative. After characterization of size, PDI, zeta potential and encapsulation efficiency, antitumour analysis using in vitro cancer cell models of breast cancer (MDA-MB-231, 4T1 and MCF7) were used to probe cytotoxic effect. Roy-functionalised AuNPs showed increased antitumour activity when compared with Roy alone, showcasing the improved antitumoral effect of the nanoformulation. In addition, the Roy-functionalised AuNPs showed selectivity for cancer cells over healthy human fibroblast (HDF) cells, a promising incentive for further development of natural diterpenoid nanosystems in cancer therapy., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Safety of nanoparticle therapies during pregnancy: A systematic review and meta-analysis

  • Gil Vives, Maria
  • Hernández Hernández, Marta
  • Hernáez, Álvaro
  • Borrós, Salvador
  • Fornaguera Puigvert, Cristina
The exclusion of pregnant women from clinical trials has led to insufficient safety data for many treatments, making it necessary to evaluate their potential benefits and risks during preclinical stages. Nanomedicines show potential for reduced toxicity but there is limited evidence about their safety for pregnant women and their fetuses. We conducted the first systematic review and meta-analysis of the effect of nanoparticles (NPs) on a key outcome of fetal toxicity (low birth weight) in murine models. In the meta-analysis of mouse models, negatively charged NPs tended to decrease birth weight (−69.8 mg, 95 % CI: −196 to 56.5), as did small (−191 mg, 95 % CI: −369 to −13.3) and plain inorganic nanosystems (−249 mg, 95 % CI: −535 to 37.4). In contrast, positively charged NPs resulted in increased birth weight (+29.3 mg, 95 % CI: 23.4 to 35.2). All findings were validated in studies with low heterogeneity and low risk of publication bias. Neither large NPs (+4.37 mg; 95 % CI: −45.3 to 54.0) nor polymer-coated NPs (+16.5 mg; 95 % CI: −44.7 to 77.6) had any clear association with birth weight. Similar results were observed in other models and experimental designs from articles not included in the meta-analysis, although no conclusions were drawn for other parameters due to high variability. Our findings pave the way for future research and the rational development of safer nanomedicines for use during pregnancy., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Sustainable encapsulation of lipophilic fragrances using biodegradable sodium alginate for cosmetic applications

  • Tarrats i Duran, Anna
  • Borrós, Salvador
  • Rodrigo Magaña, José
  • Fornaguera, Cristina
The encapsulation of lipophilic compounds for use in the cosmetic, food, and detergency industries is an area of growing interest. However, most current strategies rely on non-biodegradable materials, often classified as microplastics, which pose significant environmental risks. To address these issues, alternative encapsulation methods using biodegradable materials are being developed. Despite their potential, these methods have yet to demonstrate efficacy or economic feasibility comparable to conventional encapsulation systems. To overcome these challenges, a novel strategy has been developed for the encapsulation of lipophilic compounds, such as fragrances, using sodium alginate (SA). This approach involves the formation of an oil-in-water nanoemulsion via the Phase Inversion Composition method, with polysorbate 80 serving as the surfactant. The process is followed by the internal gelation of SA and subsequent dispersion to generate the final microcapsules. The formulation was optimized by varying the ratios of surfactant, oil, and aqueous phases in the nanoemulsion. Characterization techniques, including Dynamic Light Scattering, Gas Chromatography–Mass Spectrometry, and Thermogravimetric Analysis, confirmed successful encapsulation (average of 81 %, up to 97 % for one fragrance). The formulations demonstrated prolonged release profiles, with the scent remaining detectable for up to 30 days. An organoleptic study further revealed that encapsulated fragrances retained higher perceived intensity over time compared to their non-encapsulated counterparts. Moreover, the microcapsules exhibited excellent long-term stability within a conditioner matrix, maintaining their fragrance load for four months. This work represents a significant advancement in the development of environmentally friendly encapsulation methods for lipophilic compounds, offering promising applications in the cosmetic industry., info:eu-repo/semantics/acceptedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Ammonium trifluoroborate-modified poly(β-aminoesters): A case study for PET-guided in vivo pharmacokinetic studies of a non-viral gene delivery system

  • Cosialls, Raúl
  • Fernández, Odile
  • Simó , Cristina
  • Krishna Reddy, Pulagam
  • Guerra-Rebollo, Marta
  • Llop, Jordi
  • Fornaguera, Cristina
  • Cuenca, Ana Belen
  • Borrós, Salvador
Nucleic acid-based therapies have become a game-changing player in our way of conceiving pharmacology. Nevertheless, the inherent lability of the phosphodiester bond of the genetic material with respect to the blood nucleases severely hampers its delivery in naked form, therefore making it necessary to use delivery vectors. Among the potential non-viral vectors, polymeric materials such as the poly(β-aminoesters) (PBAEs) stand out as promising gene carriers thanks to their ability to condense nucleic acids in the form of nanometric polyplexes. To keep advancing these systems into their translational preclinical phases, it would be highly valuable to gain accurate insights of their in vivo pharmacokinetic profile. We envisaged that positron emission tomography (PET)-guided imaging could provide us with both, an accurate assessment of the biodistribution of PBAE-derived polyplexes, as well shed light on their clearance process. In this sense, taking advantage of the efficient [19F]-to-[18F]‑fluorine isotopic exchange presented by the ammonium trifluoroborate (AMBF3) group, we have designed and synthesized a new 18F-PET radiotracer based on the chemical modification of a linear poly(β-aminoester). As proof of concept, the incorporation of the newly developed 18F-PBAE into a model nanoformulation was shown to be fully compatible with the formation of the polyplexes, their biophysical characterization, and all their in vitro and in vivo functional features. With this tool in hand, we were able to readily obtain key clues about the pharmacokinetic behavior of a series of oligopeptide-modified PBAEs (OM-PBAEs). The observations described in this study allow us to continue supporting these polymers as an outstanding non-viral gene delivery vector for future applications., info:eu-repo/semantics/acceptedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

CD47 peptide-albumin cloaked mesoporous silica nanoparticles for enhanced macrophage evasion and synergistic combination therapy

  • Pontón, Iris
  • Núñez Martínez-Quintanilla, Sandra
  • Díaz-Perlas, Cristina
  • Oller-Salvia, Benjamí
  • Semino, Carlos
  • Sánchez-García, David
Upon introduction into the bloodstream, nanoparticles are rapidly enveloped by plasma proteins, forming a protein corona (PC) that typically accelerates their clearance via opsonization and macrophage uptake. However, specific proteins, such as albumin, exhibit dysopsonin properties, reducing sequestration and prolonging systemic circulation. In this study, we have developed a nanocarrier (DOX/Ce6@MSN-EMal-BSA/SP1) based on mesoporous silica nanoparticles (MSNs) coated with a light-responsive PC that prevents macrophage recognition and enables the controlled release of doxorubicin (DOX). The PC comprises bovine serum albumin (BSA) anchored to the MSN surface through a novel singlet oxygen-sensitive linker, with further functionalization using a CD47-mimetic peptide (SP1) to enhance immune evasion. BSA coating resulted in a 1.9-fold reduction in uptake by macrophage cultures compared to uncoated MSNs. Incorporation of SP1 further diminished macrophage internalization by 3.5-fold, as quantified by in vitro assays. Red light irradiation (660 nm) triggers cleavage of the singlet oxygen-sensitive linker, leading to PC shedding and subsequent DOX release. In vitro cytotoxicity evaluations against pancreatic cancer cell lines demonstrated potent efficacy: the nanocarrier exhibited an IC50 of 0.99 μg mL−1 against MIA PaCa-2 cells and 1.74 μg mL−1 against PANC-1 cells. This high cytotoxicity is attributed to a synergistic effect (CI = 0.40 for MIA PaCa-2 and 0.17 for PANC-1) resulting from the photodynamic generation of singlet oxygen by chlorin e6 (Ce6) and the chemotherapeutic action of released DOX. These findings underscore the nanocarrier's potential for precision drug delivery in combination therapeutic modalities., info:eu-repo/semantics/acceptedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Stealth mRNA nanovaccines to control lymph node trafficking

  • García-Fernández, Coral
  • Virgilio, Tommaso
  • Latino, Irene
  • Guerra-Rebollo, Marta
  • F. Gonzalez, Santiago
  • Borrós, Salvador
  • Fornaguera, Cristina
mRNA-based vaccines symbolize a new paradigm shift in personalized medicine for the treatment of infectious and non-infectious diseases. However, the reactogenicity associated with the currently approved formulations limits their applicability in autoinflammatory disorders, such as tumour therapeutics. In this study, we present a delivery system showing controlled immunogenicity and minimal non-specific inflammation, allowing for selective delivery of mRNA to antigen presenting cells (APCs) within the medullary region of the lymph nodes. Our platform offers precise control over the trafficking of nanoparticles within the lymph nodes by optimizing stealth and targeting properties, as well as the subsequent opsonization process. By targeting specific cells, we observed a potent adaptive and humoral immune response, which holds promise for preventive and therapeutic anti-tumoral vaccines. Through spatial programming of nanoparticle distribution, we can promote robust immunization, thus improving and expanding the utilization of mRNA vaccines. This innovative approach signifies a remarkable step forward in the field of targeted nanomedicine., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Metabolic engineering of Saccharomyces cerevisiae sphingolipid pathways for enhanced phytoceramide production

  • Guixeras-Carreras, Jordi
  • Caballé, Marc
  • Leivar, Pablo
  • De Mey, Marjan
  • Planas, Antoni
  • Fornaguera, Cristina
  • Artigues Cladera, Margalida
  • Faijes, Magda
Phytoceramides are essential sphingolipids that support skin barrier integrity and hydration, making them valuable for cosmetic and pharmaceutical applications. However, their intricate structures and low natural abundance pose significant challenges for scalable production. Here, we present an integrated metabolic engineering and lipidomics study aimed at enhancing phytoceramide production in Saccharomyces cerevisiae. We implemented three strategies: (i) overexpression of SUR2 (sphinganine C4-hydroxylase) to boost phytosphingolipid formation; (ii) deletion of SCS7 (ceramide α-hydroxylase) to redirect flux toward non-hydroxylated phytoceramides; and (iii) overexpression of ISC1 (inositol phosphosphingolipid phospholipase) to recycle complex sphingolipids into ceramide pools. SUR2 overexpression showed the highest transcript levels, whereas lipidomics revealed that scs7Δ produced the highest phytoceramide enrichment with a 15-fold increase in phytoceramide abundance relative to the wild type. In terms of relative abundance within the quantified ceramide pool, phytoceramides increased from 5% in wild type to 46% in the SUR2-OE strain and 75% in the scs7Δ strain. The combined scs7Δ SUR2-OE strain did not exhibit additive metabolic effects on the lipid profile. The presence of residual hydroxylated ceramides indicated intrinsic regulatory constraints, aligning with the bypass mechanism proposed here whereby ceramide synthases can use pre-hydroxylated acyl-CoA. Importantly, this work contributes a comprehensive lipidomic profiling of S. cerevisiae, enabling clear discrimination between engineered and wild type strains and identification of genotypes exerting the greatest impact on phytoceramide accumulation. This approach advances sphingolipid pathway modulation and positions S. cerevisiae as a valuable model for studying phytoceramide-focused remodeling., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A dual QTOF–QTrap analytical platform for comprehensive tracking of doxycycline and its degradation byproducts in biological and nanoparticle-based delivery systems

  • Bofill Bonet, Carles
  • Artigues Cladera, Margalida
  • Moreno-Jimenez, Ines
  • Balà, Noemí
  • Martorell, Jordi
  • Fornaguera, Cristina
  • Borrós, Salvador
Doxycycline (DOX) is a second-generation tetracycline antibiotic extensively used in clinical practice, not only for its antimicrobial activity but also for its emerging therapeutic potential in modulating extracellular matrix (ECM) in remodeling processes. Increasing evidence supports its role in attenuating pathological conditions associated with ECM degradation by targeting matrix metalloproteinases type 2 (MMP-2), including cancer progression and abdominal aortic aneurysm (AAA). However, DOX exhibits limited stability in aqueous and semi-physiological environments, undergoing hydrolysis and oxidative reactions that lead to the generation of multiple degradation byproducts, thereby compromising its efficacy and safety profile. In this study, we systematically mapped the degradation pathways of DOX under rigorously controlled physicochemical and biological conditions. High-resolution QTOF mass spectrometry operating in SWATH data-independent acquisition mode enabled unbiased identification of multiple, structurally distinct degradation byproducts, as well as the DOX parent compound, using curated metabolite libraries from SCIEX platform. Building on this annotation step, we established a complementary QTrap-based targeted workflow to quantify low-abundance metabolites intra- and extracellular through isotope-specific transitions derived from the QTOF analysis and to monitor their temporal kinetics with high sensitivity. Together, this integrated analytical strategy provides refined insight into the intrinsic instability of DOX and its potential biological consequences. To translate degradation mapping into a biologically relevant context, OM-PLGA NPs were incorporated as a controlled delivery platform that modulates DOX exposure, slows spontaneous degradation, and creates the matrix conditions required to validate the sensitivity of the QTRAP workflow in complex cellular environments. This validation demonstrated that OM-PLGA nanoparticles not only preserve DOX in its bioactive form through microenvironmental shielding, but also results in enhanced pharmacological activity, particularly sustained inhibition of MMP-2, a central enzyme in AAA-associated ECM remodeling. Together, these results highlight the dual value of the advanced analytical workflow and the nanocarrier strategy, demonstrating how integrating high-resolution mass spectrometry with nanoparticle engineering overcomes the intrinsic instability of DOX and provides deeper mechanistic insight across both analytical and biological dimensions., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Localized doxycycline delivery via polymeric nanoparticles anchored to electrospun PCL microfiber patch for MMP-2 inhibition in abdominal aortic aneurysm

  • Bofill Bonet, Carles
  • Febas, Germán
  • Artigues Cladera, Margalida
  • Moreno-Jimenez, Ines
  • Balà Palasí, Noemí
  • Martorell, Jordi
  • Borrós, Salvador
  • Fornaguera, Cristina
Doxycycline (DOXY) is a well-established antibiotic that has recently shown potential in inhibiting matrix metalloproteinase-2 (MMP-2), a key enzyme involved in the progression of abdominal aortic aneurysms (AAA). However, the controlled delivery of DOXY to the aneurysm site, with sustained release and minimal systemic exposure, remains a critical challenge in therapeutic development. To address this, we developed a targeted drug delivery platform based on polymeric nanoparticles (NPs), prepared from water-in-oil-in-water nano-emulsions, encapsulating DOXY and are covalently attached to electrospun ε-poly(caprolactone) (ε-PCL) microfibers. This system was designed to enable local, sustained drug release in the inner wall of aorta while preserving the mechanical properties of the aortic wall. The ε-PCL electrospun microfibers from the patch were first functionalized using oxygen cold plasma treatment, creating free radicals that enabled covalent bonding with chemical groups on the outer layer of DOXY-loaded poly(lactic-co-glycolic acid) (PLGA) NPs. This strategy allowed for robust immobilization of the NPs onto the microfibers surface, forming a composite system capable of localized and controlled drug release over time. Unlike traditional delivery approaches, this method ensures site-specific action of DOXY directly at the aneurysmal tissue, minimizing systemic circulation and reducing off-target toxicity. The platform not only provides a stable drug reservoir but also offers intrinsic biomechanical reinforcement, which is critical in AAA condition. This innovative delivery system represents a significant advance in the localized treatment of vascular disorders. It offers a biocompatible, biodegradable, and precisely targeted therapeutic approach, with potential to reduce the need for surgical intervention and limits the adverse effects associated with systemic drug administration., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Quantitative and qualitative comparison of mRNA loading techniques into extracellular vesicles

  • Guarro, Monica
  • van Veen, Stijn
  • Borrós, Salvador
  • Albertazzi, Lorenzo
  • Lecina, Martí
  • Fornaguera, Cristina
Extracellular vesicles (EVs) are increasingly recognized as natural therapeutic delivery systems (DDS). A critical challenge in realizing this potential is the loading of nucleic acids, particularly mRNA, a high molecular weight and very sensitive biomolecule, for which the loading efficiency into EVs is often low. Despite the growing interest in EV-based delivery platforms, relatively few studies have reported efficient loading techniques, and inconsistent or misleading information in the literature hinders progress towards the development of reliable loading of mRNA into EV-based systems. Addressing this gap systematically and quantitatively is crucial for the clinical translation of EVs as DDS. In this study, we compared five different exogenous mRNA loading methods (incubation, sonication, freeze-thaw, electroporation and extrusion) and evaluated their loading efficiencies, as well as their biophysical, biochemical, and functional properties. Here, using direct stochastic optical reconstruction microscopy (dSTORM), as an efficient and reliable characterization approach to assess mRNA loading efficiency into EVs we visualized single EVs and single mRNA molecules and to estimate the percentage of loaded EVs as well as the amount of mRNA molecules loaded per EV. Interestingly, all five strategies demonstrated a high yield of EVs associated with mRNA, with up to 70 % of EVs successfully containing or in contact with mRNA, with minimal disruption to the intrinsic properties of EVs. Although some discrepancies between loading efficiencies, functionality and amount of mRNA molecules per EV, freeze-thaw proved to be the most effective in terms of loading efficiency and amount of mRNA associated molecules per EV. Overall, mRNA incorporation using these exogenous methods remained inefficient and presented significant challenges for large-scale implementation due to substantial mRNA loss. Despite this limitation, the high proportion of successfully loaded or mRNA associated EVs, particularly with freeze-thaw and electroporation, provides, for the first time, a promising foundation for the advancing of mRNA loading on EV-based therapeutic applications., info:eu-repo/semantics/publishedVersion
e_Buah Biblioteca Digital Universidad de Alcalá
Publicación Artículo científico (JournalArticle)

Functionalised gold nanoparticles using abietane diterpenoids from "Plectranthus grandidentatus" Gürke for cancer therapy

  • Bangay, Gabrielle
  • Isca, Vera M. S.
  • Morais, João
  • Fernández Alarcón, Jennifer
  • Viana, Ana S.
  • Pinto Reis, Catarina
  • Pereira Leite, Catarina
  • Díaz Lanza, Ana María|||0000-0002-4216-3997
  • Saraiva, Lucília
  • Fornaguera, Crisitna
  • Dias de Mendonça Rijo, Patricia
Nanoparticles (NPs) are very small particles with distinct properties stemming from their nanometric size and large surface area, setting them apart from bulk materials. NPs provide many benefits, such as high drug loading capacity, specific targeting, prolonged circulation, and minimized side effects. Over the past few years, metal-based NPs, such as gold NPs (AuNPs), have gained special attention due their surface plasmon resonance properties and use in drug and gene delivery, particularly in cancer treatment and theragnostics. Abietane diterpenoids, such as 7α-acetoxy-6β-hydroxyroyleanone (Roy) isolated from Plectranthus spp., are known to be cytotoxic agents, ideal for chemotherapeutic applications. Yet, their poor water solubility and low bioavailability limit their therapeutic efficacy. Harnessing the effectiveness of AuNPs, several nanosystems were made using Roy, the natural diterpene, and an ester derivative. After characterization of size, PDI, zeta potential and encapsulation efficiency, antitumour analysis using in vitro cancer cell models of breast cancer (MDA-MB-231, 4T1 and MCF7) were used to probe cytotoxic effect. Roy-functionalised AuNPs showed increased antitumour activity when compared with Roy alone, showcasing the improved antitumoral effect of the nanoformulation. In addition, the Roy-functionalised AuNPs showed selectivity for cancer cells over healthy human fibroblast (HDF) cells, a promising incentive for further development of natural diterpenoid nanosystems in cancer therapy., Fundação para a Ciência e a Tecnologia (FCT), AGAUR-Generalitat de Catalunya, ACCIO-Generalitat de Catalunya, Generalitat de Catalunya, Agencia Estatal de Investigación